Stocks and Investing Stocks and Investing
Fri, March 11, 2022

David Amsellem Maintained (AMPH) at Buy with Increased Target to $35 on, Mar 11th, 2022


Published on 2024-10-27 20:02:49 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Amphastar Pharmaceuticals, Inc." (AMPH) at Buy with Increased Target from $28 to $35 on, Mar 11th, 2022.

David, nor any peers, have made any analyst calls on AMPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources